Browse the evidence

Oriental Melon Stem Ethanol Extract (CMSE) reduces body weight and fat mass in high-fat diet-induced obese mice by increasing energy expenditure and enhancing brown adipose tissue thermogenesis, independent of calorie intake.

If you are looking for a supplement to support weight management, Oriental Melon Stem Extract (CMSE) shows promise in animal studies for boosting metabolism and burning fat without needing to eat less. The effective dose in mice translates to a high daily intake for humans (~2.3g), which falls within the range of dietary supplements. While not a magic bullet, it may support metabolic health and liver function when combined with a balanced diet.

GLP-1 receptor agonist therapy (semaglutide/tirzepatide) is increasingly driving referrals for post-weight-loss body contouring, with referral volumes growing faster than those from lifestyle modification or bariatric surgery.

If you are using GLP-1 medications like Ozempic or Mounjaro, be aware that rapid weight loss often leads to excess skin. You may need to consult a plastic surgeon for body contouring procedures. This is a common and expected outcome of significant weight loss via these medications.

In type 2 diabetes, worsening chronic glycaemic control (higher HbA1c) shifts endogenous GIP action from insulinotropic to glucagonotropic, strengthening the correlation between GIP and glucagon secretion while weakening its correlation with insulin.

For people with Type 2 Diabetes, the effectiveness of the body's natural GIP response depends heavily on how well blood sugar is controlled. If HbA1c is high, GIP may contribute to higher glucagon (raising blood sugar) rather than helping insulin. This suggests that managing baseline blood sugar is crucial for optimizing natural hormonal responses.

Expanding first-level genetic screening for obesity to include POMC and MC3R genes is necessary to maximize diagnostic yield and identify patients with intermediate susceptibility phenotypes who are missed by standard panels.

If you have obesity and standard genetic tests came back negative, ask your doctor about expanded testing for POMC and MC3R genes. This can reveal if you have a specific biological susceptibility that might affect how your body handles energy, potentially guiding more personalized treatment strategies.

GLP-1 and dual GIP/GLP-1 receptor agonists exert neuropsychiatric effects by modulating central neurotransmitter systems (dopamine, serotonin, GABA, glutamate) and promoting neuroplasticity, potentially treating addiction, depression, and cognitive decline.

GLP-1 and dual agonists (like semaglutide and tirzepatide) do more than just suppress appetite; they interact with brain receptors that regulate mood, reward, and memory. While they are primarily prescribed for diabetes and weight loss, research suggests they may also help with conditions like addiction, depression, and cognitive decline by balancing neurotransmitters like dopamine and serotonin. However, patients should be aware that while serious psychiatric side effects are rare and not consistently linked to the drugs, isolated reports of mood changes exist, so monitoring mental health is recommended.

GLP-1RAs are associated with rare but serious adverse events including acute pancreatitis, gallbladder disease, and potential worsening of diabetic retinopathy, though causal relationships for some (like thyroid cancer) are not confirmed in humans.

Be aware of rare but serious side effects like pancreatitis, gallbladder disease, and worsening of diabetic retinopathy (especially if you have pre-existing eye disease). While the risk of thyroid cancer is a concern in animal studies, no human cases have been confirmed. Report any severe abdominal pain or vision changes to your doctor.

Topical cosmetic peptides (e.g., GHK-Cu, Matrixyl, Argirelin) reduce wrinkles and improve skin firmness with excellent safety profiles, though effects are modest and require consistent long-term use.

Topical peptides like GHK-Cu, Matrixyl, and Argirelin can help reduce wrinkles and improve skin firmness when applied consistently over 8-12 weeks. They are generally safe and well-tolerated, but the effects are modest compared to injectable treatments. Regular use is necessary to maintain benefits.

High-dose tirzepatide (10–15 mg/week) is associated with a statistically significant increase in the risk of acute kidney injury (AKI) compared to control treatments.

If you are prescribed high-dose tirzepatide (10-15 mg/week), be aware of a small but statistically significant increased risk of acute kidney injury. Stay well-hydrated, especially if you experience gastrointestinal side effects like nausea or diarrhea, as volume depletion can trigger AKI. Monitor your kidney function as recommended by your doctor, and report any sudden changes in urination or swelling immediately.

Resistance training frequency (2x vs 4x per week) does not significantly alter patellar tendon morphological adaptations (Cross-Sectional Area or Length) when volume is equated.

Do not expect your tendons to get thicker (hypertrophy) from 8-12 weeks of resistance training, regardless of whether you train 2 or 4 times a week. Focus on strength gains, which can occur without visible morphological changes in this timeframe.

In routine clinical practice, sporadic individual dietary consultations do not significantly improve adherence to the Mediterranean diet in patients with type 2 diabetes.

If you have type 2 diabetes, simply attending a dietitian appointment once or twice a year is unlikely to change your diet significantly. To get results, you need intensive, ongoing support that provides concrete tools and food, not just sporadic advice. If you feel you already know how to eat well, focus on maintaining that consistency rather than seeking more general advice.

In Korean adults, adherence to a low-carbohydrate diet (LCD) is associated with higher odds of metabolic syndrome, primarily because LCDs in this population often substitute refined carbohydrates with processed meats and animal fats rather than healthy unsaturated fats.

If you are Korean or have an East Asian metabolic profile, simply reducing carbohydrates may not lower your metabolic syndrome risk and could potentially increase it if you replace rice with processed meats or unhealthy fats. Focus on the quality of your diet—choosing whole grains, unsaturated fats, and lean proteins—rather than just cutting carbs.

There is no significant difference between various macronutrient dietary groups (VLCLP, MCLP, MCHP, etc.) in their ability to lower blood glucose, blood pressure, or total cholesterol compared to a moderate fat-low protein (MFLP) control diet.

Do not expect that switching to a specific macronutrient ratio (like Keto or Low Fat) will significantly lower your blood pressure, blood glucose, or total cholesterol compared to a standard moderate-fat diet. The evidence for these specific outcomes is weak and shows no clear winner among the diets studied.

The protective effect of psychological resilience on physical disability and grip strength is attenuated in individuals with frequent hospitalizations (2+ per year).

If you have been hospitalized frequently, psychological resilience might not be enough to maintain your physical strength on its own. This doesn't mean resilience is worthless, but it suggests that for those with high medical burden, resilience must be supported by robust medical care and physical therapy. Focus on preventing hospitalizations to allow resilience to do its protective work.

Chronic low-grade inflammation and oxidative stress in MASLD drive atrial structural and electrical remodeling, creating an arrhythmogenic substrate for AF.

Treating MASLD involves more than just liver health; it requires addressing systemic inflammation and oxidative stress to protect the heart from structural remodeling that leads to AF.

Central administration of leptin or FGF1 can reverse basal hyperglycemia in diabetic animal models through insulin-independent mechanisms, without improving glucose tolerance.

This finding in animals suggests that targeting the brain with specific hormones (like leptin or FGF1) can lower blood sugar without needing insulin. This supports the development of brain-targeted therapies for diabetes that work independently of pancreatic insulin secretion.

Integrase Strand Transfer Inhibitor (INSTI) use was associated with a lower risk of progression from prediabetes to diabetes compared to Protease Inhibitor (PI)-based ART in a specific subset of participants, contrasting with some other observational studies.

This paper's finding that INSTIs might have a lower diabetes risk than PIs in a small group is not definitive. Do not change your medication based on this alone. Focus on the proven risk factors: manage your weight, waist circumference, and triglycerides through lifestyle changes, as these have a stronger and more consistent link to diabetes progression.

Insulin-lowering dietary strategies (calorie restriction, ketogenic/low-carbohydrate diets, and intermittent fasting) reduce systemic insulin and IGF-1 levels, which attenuates insulin-related growth signaling and reduces metastatic disease burden in preclinical animal models.

For metastatic cancer patients, insulin-lowering diets (like low-carb or intermittent fasting) are safe and feasible adjuncts to standard care. They improve metabolic markers (insulin, glucose) and may help control disease, but they are not yet proven to extend survival. Consult your oncology team to implement these strategies safely, ensuring they do not exacerbate weight loss or cachexia.

Specific essential minerals (Calcium, Potassium, Magnesium, Iron) are critical cofactors for immune cell metabolic reprogramming (glycolysis vs. oxidative phosphorylation) and polarization (M1 pro-inflammatory vs. M2 pro-resolution).

Immune cells change their energy usage based on their function (inflammation vs. healing). Essential minerals like Calcium, Potassium, and Magnesium are required for these metabolic switches to function correctly. Deficiencies may lock immune cells in a pro-inflammatory state.

GLP-1 receptor agonists (GLP-1 RAs) show promise as gerotherapeutic drugs by protecting against aging-related risk factors such as oxidative stress, cellular senescence, and inflammation, and may reverse brain aging and prevent sarcopenic obesity, although lifespan extension in humans is not yet reported.

If you are considering GLP-1 RAs for weight loss, discuss with your doctor their potential anti-aging benefits, such as reducing inflammation and protecting against cellular senescence. While they are not yet proven to extend lifespan in humans, they may offer significant healthspan benefits.

In individuals with type 2 diabetes and existing complications, a 5-day prolonged fasting-mimicking diet followed by a glucose load significantly reduces cellular resistance to dicarbonyl stress and increases oxidative stress markers, indicating heightened susceptibility to metabolic harm upon refeeding.

If you have Type 2 Diabetes with known complications (like kidney or nerve issues), extreme fasting followed by a large carbohydrate load may stress your cells more than it helps them. While fasting can improve insulin sensitivity in some, it appears to reduce your cells' ability to handle stress in this specific subgroup. Consult your doctor before attempting prolonged fasting, as your body may react with increased oxidative stress rather than metabolic improvement.

Body size metrics (BMI, waist circumference) factor load independently of cardiometabolic health metrics (lipids, blood pressure), suggesting they are distinct latent constructs rather than a single unified 'obesity' phenotype.

Your health is not defined solely by your weight. This study shows that body size and metabolic health (like blood pressure and cholesterol) are distinct factors. You can improve your metabolic health through weight-neutral approaches (like focusing on nutrition and activity without emphasizing weight loss) without needing to lose weight first. This reduces stigma and may improve engagement with health behaviors.

Intensive lifestyle intervention (weight loss, reduced caloric intake, increased physical activity) does not significantly prevent diabetic peripheral neuropathy in patients with Type 2 Diabetes Mellitus (T2DM) and may have negative effects in some contexts.

While weight loss is generally good for health, aggressive lifestyle interventions alone may not prevent nerve damage in Type 2 Diabetes and should not replace standard glycemic management.

Time-restricted eating combined with calorie restriction does not provide significant additional benefits for blood pressure, glucose profile, or lipid profile compared to calorie restriction alone.

Do not expect time-restricted eating to fix your blood pressure, blood sugar, or cholesterol if you are just counting calories. The benefits for these markers are not significantly better than just counting calories alone. Focus on the weight loss aspect of TRE.

Sulfur amino acid restriction (SAAR) induces transcriptional remodeling in white adipose tissue (WAT), upregulating ribosomal processes and downregulating structural components, without significantly altering classical metabolic risk biomarkers like lipids or glucose.

While you won't see immediate changes in your cholesterol or blood sugar, your fat tissue is biologically changing at the genetic level. Specifically, your cells are adjusting their protein synthesis machinery (ribosomes) and structural components, which may support long-term metabolic health.